Emerson Electric Co.
NYSE:EMRIndustrial - Machinery
+$2.10 today
- Market cap
- $88.87B
- Beta
- 1.25
- P/E (TTM)
- 34.7
- EPS (TTM)
- $4.36
- Dividend yield
- 1.45%
Volume 2.90M
Average 2.88M
EMR Sales of Investments
Cash received from selling or redeeming investments.
Emerson Electric Co.NYSE: EMR
Sales of Investments · Q3 FY2026 · quarter ended Jun 2026
Sales of investments outflow grows to $0
Q3 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, down 0.5 pp from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | -100.0% |
| FY2024 | 2024-09-30 | 79M | -55.1% |
| FY2023 | 2023-09-30 | 176M | -59.8% |
| FY2022 | 2022-09-30 | 438M | — |
| FY2021 | 2021-09-30 | 0 | — |
Sales of Investments vs competitors
How EMR compares with its peers on the latest reported figures
- EMR's LTM Jun 2026 sales of investments of $0 is the 2nd largest of the 8 companies compared; the peer median is $0.
- Sales of investments amounts to 0.0% of revenue for EMR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2M | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding EMR) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for EMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 1.42B | 1.88B | 2.26B | 1.61B | 2.25B |
| Depreciation & Amortization | 762M | 842M | 1.05B | 1.69B | 1.52B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 197M | 125M | 250M | 260M | 263M |
| Change in Working Capital | 167M | (312M) | (148M) | (151M) | (9M) |
| Accounts Receivables | (18M) | (143M) | (191M) | (99M) | (171M) |
| Inventory | (11M) | (334M) | (160M) | 122M | (1M) |
| Accounts Payables | 107M | 147M | (17M) | (16M) | 34M |
| Other Working Capital | 89M | 18M | 220M | (158M) | 129M |
| Other Non-Cash Items | 1.03B | 384M | (2.78B) | (71M) | (920M) |
| Operating Cash Flow | 3.58B | 2.92B | 637M | 3.33B | 3.1B |
| Capital Expenditures | (581M) | (531M) | (363M) | (419M) | (431M) |
| Acquisitions (Net) | (1.58B) | (4.66B) | (705M) | (8.34B) | 0 |
| Purchases of Investments | 0 | (438M) | 363M | 0 | 0 |
| Sales of Investments | 0 | 438M | 176M | 79M | 0 |
| Other Investing Activities | 38M | (140M) | 12.94B | 3.32B | (162M) |
| Investing Cash Flow | (2.12B) | (5.33B) | 12.42B | (5.36B) | (593M) |
| Debt Repayment | (812M) | 3.69B | (3.24B) | (567M) | 5.24B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (500M) | (500M) | (2.21B) | (643M) | (1.24B) |
| Dividends Paid | (1.21B) | (1.22B) | (1.2B) | (1.2B) | (1.19B) |
| Other Financing Activities | 100M | 80M | (169M) | (44M) | (7.32B) |
| Financing Cash Flow | (2.42B) | 2.05B | (6.82B) | (2.46B) | (4.51B) |
| Effect of Forex Changes | 6M | (186M) | 18M | 20M | (39M) |
| Net Change in Cash | (961M) | (550M) | 6.25B | (4.46B) | (2.04B) |
| Free Cash Flow | 2.99B | 2.39B | 274M | 2.91B | 2.67B |
Emerson Electric Co.
NYSE:EMR
Intrinsic Alpha fair value
Locked
Current Price
$162.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.